510(k) · Cleared
ClearedEsensor Cystic Fibrosis Carrier Detection System, Model Esensor 4800
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Clinical Micro Sensors, Inc. · NUA System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection
Cleared on Mar 28, 2006 as substantially equivalent to K051435 (Clinical Micro Sensors, 2006) after a 27-day review. Its family tree reaches back 2 generations to 2005. 2 later devices descend from it.
- Decided
- Mar 28, 2006
- Review
- 27 days
- Class
- Class II
- Product code
- NUA
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 2 generations to DEN050004 (2005). 2 later devices descend from it, 1 citing it directly.
- Root · 2 generations backDEN050004 Tag-IT Cystic Fibrosis KitTm Bioscience Corporation · 2005
- 1 generation backK051435 Esensor Cystic Fibrosis Carrier Detection Test , Esensor 4800 Dna…Clinical Micro Sensors · 2006
- This deviceK060543 Esensor Cystic Fibrosis Carrier Detection System, Model Esensor 4800Clinical Micro Sensors, Inc. · 2006
- Descendant · cites it directly · 1 of its ownK090901 Esensor CF Genotyping Testm Esensor System, Esensor Cystic Fibrosis…Osmetech Molecular Diagnostics · 2009 · Recalled
- Descendant · 2 generations on · 0 of its ownK093974 Esenor Fii-FV-Mthfr Genotyping Test, Esenor Fii-FV Genotyping Test…Osmetech Molecular Diagnostics · 2010
Most influential descendants
Showing 2 of 2 · See all- K090901Esensor CF Genotyping Testm Esensor System, Esensor Cystic Fibrosis Genotyping Test…Osmetech Molecular Diagnostics · 2009 · cites it directly1descendant
- K093974Esenor Fii-FV-Mthfr Genotyping Test, Esenor Fii-FV Genotyping Test, Esenor Fii GenotypingOsmetech Molecular Diagnostics · 2010 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | DEN050004 | Tag-IT Cystic Fibrosis Kit | Tm Bioscience Corporation | 2005 | — |
| −1 | K051435 | Esensor Cystic Fibrosis Carrier Detection Test , Esensor 4800 Dna Detection… | Clinical Micro Sensors | 2006 | — |
| 0 (this device) | K060543 | Esensor Cystic Fibrosis Carrier Detection System, Model Esensor 4800 | Clinical Micro Sensors, Inc. | 2006 | — |
| +1 | K090901 | Esensor CF Genotyping Testm Esensor System, Esensor Cystic Fibrosis Genotyping… | Osmetech Molecular Diagnostics | 2009 | 2 |
| +2 | K093974 | Esenor Fii-FV-Mthfr Genotyping Test, Esenor Fii-FV Genotyping Test, Esenor Fii… | Osmetech Molecular Diagnostics | 2010 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NUA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K051435 | Esensor Cystic Fibrosis Carrier Detection Test , Esensor 4800 Dna Detection System…Summary page 1…Micro Senss, Inc. eSensoit Cystic Fibrosis Carrier Detection Systen Special 530k notification (original 530k ref: k051435) eSensor® Cystic Fibrosis Carrier Detection System 510(k) Summary… | 2006 |
What descends from it? (2)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K090901 | Esensor CF Genotyping Testm Esensor System, Esensor Cystic Fibrosis Genotyping Test… | 2009 | 1 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 1 year and passes through 3 companies; a new generation was cleared every 8 months on median.
- None of the 2 ancestors has a recall.
- Of its descendants, K090901 (Osmetech Molecular Diagnostics, 2009) has gone furthest, with 1 descendant of its own.
- 1 other device also cites its predicate K051435.
How does its category compare?
All NUA devicesNUA System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · NUA
2in 2016
2026 to Oct 25, outlined.
Median 510(k) review, days · NUA
254in 2009
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · NUA
No recall names NUA since 2007.
Adverse event reports per year · NUA
1in 2013
MAUDE reports naming product code NUA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 1 | — | 0 | 0 |
| 2009 | 4 | 254 | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 1 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 2 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The eSensor® Cystic Fibrosis Carrier Detection (CFCD) System is a device for the detection of carrier status for cystic fibrosis for all adult couples contemplating pregnancy, regardless of ethnicity. It is a qualitative genotyping assay that simultaneously detects mutations currently recommended by the American College of Medical Genetics and American College of Obstetricians and Gynecologists (ACMG/ACOG). The eSensor® CFCD System is not indicated for prenatal screening or for diagnostic purposes, and is for Rx only professional use within the confines of a licensed laboratory, as defined by the Clinical Laboratory Improvement Amendments (CLIA) of 1988.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K060543 · printed Nov 4, 2026
Cite this page
510(k) Report. “K060543: Esensor Cystic Fibrosis Carrier Detection System, Model Esensor 4800.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K060543
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026